The development of Internet technologies and the WWW has dramatically influenced all aspects of modern life. Is their development also beneficial for drug discovery? This article reviews advantages of web technologies and their influence on the drug discovery process.
INTRANET TOOLS IN PHARMA COMPANIES
Currently, major large pharma companies use Web technology for the Intranet data analysis of small molecules [1] [2] [3] [4] [5] . There are at least several clear advantages why companies are investing in the development of web technologies.
• Available everywhere. The Web tools are accessible on different platforms thus allowing the users to work in the environment they prefer. This eliminates need to spend resources for training of end-users to work with program installed on specialized systems such as Linux, Unix, etc. The training of employers to use Web tools requires less time. The users are usually well familiar to use Internet and browsers. There is also a minimal danger to the misuse of the software and to damage the system or the program by an accident or virus infection. The Web drug discovery tools covers a large range of applications from molecular property calculations, bioisosteric design to virtual screening and docking as summarized in ref [1] .
The wide-spread usage of Web tools in the Industry does not however, imply, that the development of such tools is easy. The interface of the Web-tool should be simple and intuitive, have only a minimum number of input parameters and clear logic of data processing as well as are documented in help files. Complex interfaces will increase the possibility of user mistakes and may lead to invalid and nonsense results. All these issues should be carefully considered when developing the Web interfaces.
Since the development of Web tools may require considerable resources, it is not surprisingly that companies offering such services appear. One example of such companies is the Pipeline Pilot from SciTegic (http://accelrys.com). It provides a platform for an easy data integration and publishing via Webports.
Of course, because of the proprietary nature of drug discovery, researchers in pharmaceutical industry are usually not allowed submission of their structures and datasets or/and post questions that can disclosure their work to Web outside of the company intranet. Because of these limitations, the scientists cannot easily use public services to post their questions and exchange information. However, it does not prevent them to implement private versions of useful public tools on the in house Intranet, as it is the case with Pfizer's version of Wikipedia, Pfizerpedia [6] .
PUBLIC WWW RESOURCES
There is a growing interest in developing public and free Web tools for drug discovery on the Internet. These developments are equally supported both by Academia and commercial firms. The publishing or making the software publicly available on the Internet does not contradict the idea of its successful marketing. Indeed, considering the extremely importance of privacy of data in Industry, no commercial users will ever use public resources for analysis of their compounds. Thus, by making software freely available online commercial firms do not loose potential customers. However, freely available accessible tools offer a great possibility of testing the algorithms. If users are satisfied with the results, they can decide to buy the software.
The need for confidentiality is much less in Academia. Of course, academic studies do lead to the development of new drugs. However, the main target of these studies is usually not to develop a final drug molecule but to understand mechanisms of action of compounds. The molecules used in such studies can easily have poor ADME/T properties and are unlikely good lead candidates. Therefore, the value of the molecular structure by itself is not so important in these studies and there are no strict limitations to analyze these molecules at public servers.
Public or freely downloable resources includes visualization tools (Rasmol http://www.openrasmol.org, Jmol http:// jmol.sourceforge.net), software development tools (CDK http://cdk.sourceforge.net), docking software (ArgusLab http://www.arguslab.com), molecular property prediction and calculation of descriptors (PreADME http://preadme. bmdrc.org) are comprehensively reviewed in refs [14] [15] [16] [17] . The Virtual Computational Chemistry Laboratory (VCC LAB http://www.vcclab.org) represents an example of such Fig. (1) . Free interactive calculation of physico-chemical properties at Virtual Computational Chemistry Laboratory site (http://www.vcclab.org). The results of ALOGPS [7] as well as of several popular public (KOWWIN [8] , XLOGP2 [9] and XLOGP3 [10] ) and commercial programs, including Molinspiration (http://www.molinspiration.com), Pharma Algorithms (http://www.ap-algorithms.com), Cosmologic GmBH (http://www.cosmologic.de), Actelion property explorer (http://www.actelion.com), ALOGP [11] and MLOGP [12] (implemented in Dragon software [13] ) are displayed at one page. The on-line access to PHYSPROP database (http://www.syrres.com/esc/ physdemo.htm) is also used to provide experimental values (if available) of the analyzed compound.
services for drug discovery [18] . It includes tools for physico-chemical property prediction (see Fig. 1 
CHEMO-AND BIOINFORMATICS DATABASES
A large number of chemoinformatics and bioinformatics databases important for drug discovery are available on the Internet. This includes major commercial databases, such as Beilstein (http://www.beilstein.com) and Gmelin databases (http://info.crossfiregmelin.com), which comprises literature data on activities and physico-chemical properties of 8.2 million compounds and 10 million reactions or iResearchLibrary (http://www.chemnavigator.com), which tracks over 46 million compounds available from > 240 chemistry suppliers. These databases can be queried on-line to detect compounds with particular activity or properties to be used, e.g. in structure-activity relationship studies or patent search.
There is also a growing number of free online databases which offering some similar functionality. For example, ZINC database (http://zinc.docking.org/) offers 4.6 million compounds in 3D format that can be used in docking. The PubChem database (http://pubchem.ncbi.nlm.nih.gov) provides information on biological activities of small molecules as part of the NIH Molecular Libraries Roadmap Initiative. It also has a growing repository of about 20 million compounds collected from different sources. All these data can be freely downloaded and used in the drug discovery process. Another example is http://www.chemspider.com, which provides on-line access to about 18 million compounds and also include literature search and property prediction software. The other databases such as NIST databases (http://www.nist.gov/srd/), FDA Drug Database (http://www. accessdata.fda.gov/scripts/cder/drugsatfda), Drug Bank (http://www.drugbank.ca/), Distributed Structure-Searchable Toxicity (DSSTox) Database (http://www.epa.gov/ncct/ dsstox) represent more specialized resources that can be used for search of drugs and their properties.
Contrary to chemoinformatics, bioinformatics databases are usually freely available. These are resources for sequence analysis and annotation, e.g. ExPASy, http://expasy.org, Ensembl, http://www.ensembl.org, MIPS, http://mips.gsf.de, metabolomic pathways, e.g. KEGG (http://www.genome.jp/ kegg), drug metabolism, e.g. HMDB (http://www.hmdb.ca), Protein data Bank (http://www.wwpdb.org) and others [19] . All these resources can be useful in drug discovery projects for the identification of potential drug targets (e.g., detection of pathogenicity islands by comparison of genomes of pathogen and non-pathogen microorganisms) or analysis of resistance to drugs of microorganisms due to SNP (single nucleotide polymorphism) or analysis of ADME/T properties of investigated compounds.
LITERATURE DATABASES AND THE OPEN AC-CESS INITIATIVE
The data mining of literature may also generate important knowledge for drug discovery. For example, by analyzing the literature one can determine new metabolic pathways or discover side effects of already known drugs, which can potentially lead to new drug targets. Such important knowledge, however, may be hidden in the article as secondary results.
Considering the growing mountain of life science data an automatic contextual text data mining can become very important in revealing these hidden pearls of information [20] . A systematic processing of abstracts available in PubMed (http://www.ncbi.nlm.nih.gov/entrez) or full text of articles provided by large publishers such as Elsevier (http://www. sciencedirect.com) can be used to make new discoveries "in textico". This field is very actively developing and it was unimaginable before the expansion of the Internet and the publication of articles in digital format. Unfortunately, the subscription to journals can be rather expensive or have limitations on the number of articles that can be automatically retrieved. This may change with the Open Access initiative (www.soros.org/openaccess) intended to provide free Web access to all published research articles and has lead to establishment of Public Library of Science (http://www.plos.org).
WEB SERVICES AND WORK FLOWS
Web publishing using static or dynamic HTML pages is convenient for interactive analysis of information. This type of publishing, however, is not convenient if one wants to do an automated data processing in a work-flow. The automation of HTML-based servers may require development of fragile screen-scraping integration scripts to extract information from one page and to introduce it to another. A small change in the output of Web pages may break the whole integration process. The cure against such integration is well known as Web services, i.e. Web pages specifically developed for automatic data processing. Development of Web services using XML-based protocols can to great degree solves problem of data inconsistency. A growing number of web services in life science were recently reviewed [21] . Moreover, the development of the Semantic Web (http:// www.w3.org/2001/sw) may bring new ways of publishing scientific articles by including comprehensive experimental results in structured format. This will provide a new dimension for automatic processing of information.
The integration of Web services can still require some time and expertise. A new development in this field is Taverna [22] which provides a graphical interface for management and integration of Web Services. In addition to Taverna one can also use pipe-lining and workflow development using both commercial, e.g. previously mentioned Pipeline Pilot (http://accelrys.com), and open source providers such as KNIME (http://knime.org). A nice overview of different tools for development of WorkFlow technologies is provided at http://openwetware.org/wiki/Abhishek_Tiwari:Workflow_ technology.
CONCLUSIONS
Interactive Web tools, on-line access to chemo and bioinformatics databases and on-line access to millions of articles provides resources that were unimaginable in the drug discovery field just 10-15 years ago. The famous law "A couple of months in the laboratory can save a couple of hours in the library" discovered last century by Harvard chemistry professor F.H. Westheimer should be rephrased by changing the word "library" to the "Internet". This is, however, only true if we sit in the right library, use the right tools and understand their limitations. Too much and noisy information can be more harmful than its absence. "It is much better to offer no answer with a clear explanation than to provide numbers without any meaning" was concluded by Ertl et al. [1] . However, even understanding this problem does not solve it, until there are no reliable methods to evaluate the quality of prediction [23] .
Hopefully, the same Internet that brought us the ocean of information can also be used to wash it out by automatic detection and elimination of contradictory results. The adding of layers of intelligence to validate retrieved information and to separate gold from ash will be important to speeding up drug discovery in years to come.
